This includes USD 100 million to advance R&D of its neglected tropical disease program, focusing on novel drug candidates for four diseases.
The unit is an oral manufacturing facility at Jedcherla, Hyderabad
Technology Development Board supports commercialisation of Metal Injection Molding of implants
It’s the company’s fourth manufacturing site worldwide. Others are located in the US, UK and China
Nureca Ltd has reported financial results for the period ended June 30, 2021.
The company posted net profit of Rs.594.6 crores for the period ended June 30, 2020.
Excluding Vacaville-related business, organic CER sales growth reached the low-teens with improved CORE EBITDA margins, in line with Lonza’s CDMO Organic Growth Model
The base Gland business posted ?11,790 million in revenue, up 16% YoY
The rating on senior secured notes issued by Biocon Biologics Global PLC was also upgraded to ‘BB+.’
Subscribe To Our Newsletter & Stay Updated
